PMID- 19771908 OWN - NLM STAT- MEDLINE DCOM- 20110609 LR - 20120622 IS - 2096-7993 (Print) IS - 2096-7993 (Linking) VI - 23 IP - 12 DP - 2009 Jun TI - [The expression of oncogene AKT2 in laryngeal squamous cell carcinoma and its clinical significance]. PG - 539-41, 545 AB - OBJECTIVE: To investigate the expression and clinical significance of oncogene AKT2 in laryngeal squamous cell carcinoma (LSCC). METHOD: The expression of AKT2 protein was measured with immunohistochemistry (Elivision two steps) in 60 cases of LSCC tissue, 28 cases of peri-cancer tissue and 16 cases of normal laryngeal epithelium, the relationship between AKT2 expression and clinical pathologic factors in LSCC was also analyzed. RESULT: The positive rates of AKT2 protein expression in LSCC and peri-cancer tissue were 56.7% (34/60), 14.3% (4/28) respectively. There was no expression of AKT2 in normal laryngeal epithelium. The positive rate of AKT2 protein expression in LSCC was significantly higher than that in peri-cancer tissue and normal laryngeal epithelium (P < 0.05, respectively). The positive rate of AKT2 was correlated with tumor site, lymph node metastasis and clinical stage of LSCC (P < 0.05, respectively), but wasn't correlated with patient's age, sex, and T stage (P > 0.05, respectively). CONCLUSION: AKT2 might play an important role in the tumorigenesis and development of LSCC, and it was suggested that AKT2 could be a useful marker for predicting tumorigenesis, invasion and metastasis potential of LSCC. FAU - Chen, Yingchao AU - Chen Y AD - Department of Otolaryngology Head and Neck Surgery, the Central Hospital of Xiaogan, Xiaogan, 432100, China. FAU - He, Yuanping AU - He Y FAU - Zhang, Shaorong AU - Zhang S FAU - Li, Lixiang AU - Li L FAU - Zhu, Xinhua AU - Zhu X FAU - Liu, Yuehui AU - Liu Y LA - chi PT - English Abstract PT - Journal Article PL - China TA - Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi JT - Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery JID - 101303164 RN - EC 2.7.11.1 (AKT2 protein, human) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) SB - IM MH - Adult MH - Aged MH - Carcinoma, Squamous Cell/*metabolism/pathology MH - Female MH - Humans MH - Laryngeal Mucosa/metabolism/pathology MH - Laryngeal Neoplasms/*metabolism/pathology MH - Lymphatic Metastasis MH - Male MH - Middle Aged MH - Neoplasm Staging MH - Prognosis MH - Proto-Oncogene Proteins c-akt/*metabolism EDAT- 2009/09/24 06:00 MHDA- 2011/06/10 06:00 CRDT- 2009/09/24 06:00 PHST- 2009/09/24 06:00 [entrez] PHST- 2009/09/24 06:00 [pubmed] PHST- 2011/06/10 06:00 [medline] PST - ppublish SO - Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Jun;23(12):539-41, 545.